EUVIMEDEUVIMED entdecken
Kommentar

Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B

Seyfettin Köklü

The Turkish Journal of Gastroenterology · 2014

DOI: 10.5152/tjg.2014.0005 ↗

Kurz gefasst

Kommentar in der Zeitschrift The Turkish Journal of Gastroenterology, 2014. Verfasst von Seyfettin Köklü. Beteiligte Einrichtung: Department of Gastroenterology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis B, Chronic, Liver Neoplasms, Patient Acuity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis B, ChronicLiver NeoplasmsPatient AcuityAntiviral AgentsFemaleHumansLiver CirrhosisMale

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Zitieren

APA

Köklü, S. (2014). Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B. The Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2014.0005

Vancouver

Köklü S. Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B. The Turkish Journal of Gastroenterology. 2014. doi:10.5152/tjg.2014.0005

BibTeX
@article{Kkl2014,
  author = {Köklü, Seyfettin},
  title = {Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B},
  journal = {The Turkish Journal of Gastroenterology},
  year = {2014},
  doi = {10.5152/tjg.2014.0005}
}
Kostenlos starten →